Search research articles
Contact Us
Filters
Showing results (121-130 of 198) with videos related to
Page
of 20
Sort By:
Journal of Addiction Science
|
May 21, 2020
Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency
Drew Edwards, A Kenison Roy, Brent Boyett, et al.
Journal of Systems and Integrative Neuroscience
|
December 12, 2019
Death by Opioids: Are there non-addictive scientific solutions?
B William Downs, Kenneth Blum, David Baron, et al.
International Journal of Spine Surgery
|
July 11, 2025
Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine Homeostasis
Kai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Sergio Schmidt, et al.
Clinical and Experimental Psychology
|
June 26, 2023
Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?
Kenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Substance Abuse and Rehabilitation
|
January 31, 2025
Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk
Richard Paul Green, Kenneth Blum, Kai Uwe Lewandrowski, et al.
International Journal of Environmental Research and Public Health
|
November 13, 2021
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions
Kenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Journal of Personalized Medicine
|
April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J Modestino, et al.
EC Psychology and Psychiatry
|
February 1, 2024
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction
Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, et al.
Liver Cancer
|
May 11, 2026
Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib
Amit Mahipal, Ann-Lii Cheng, Masatoshi Kudo, et al.
Journal of Personalized Medicine
|
December 29, 2022
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family
Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 198) with videos related to
Sort By:
Page
of 20
Journal of Addiction Science
|
May 21, 2020
Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency
Drew Edwards, A Kenison Roy, Brent Boyett, et al.
Journal of Systems and Integrative Neuroscience
|
December 12, 2019
Death by Opioids: Are there non-addictive scientific solutions?
B William Downs, Kenneth Blum, David Baron, et al.
International Journal of Spine Surgery
|
July 11, 2025
Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine Homeostasis
Kai-Uwe Lewandrowski, Rossano Kepler Alvim Fiorelli, Sergio Schmidt, et al.
Clinical and Experimental Psychology
|
June 26, 2023
Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?
Kenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Substance Abuse and Rehabilitation
|
January 31, 2025
Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk
Richard Paul Green, Kenneth Blum, Kai Uwe Lewandrowski, et al.
International Journal of Environmental Research and Public Health
|
November 13, 2021
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions
Kenneth Blum, Abdalla Bowirrat, Eric R Braverman, et al.
Journal of Personalized Medicine
|
April 3, 2021
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J Modestino, et al.
EC Psychology and Psychiatry
|
February 1, 2024
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction
Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, et al.
Liver Cancer
|
May 11, 2026
Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib
Amit Mahipal, Ann-Lii Cheng, Masatoshi Kudo, et al.
Journal of Personalized Medicine
|
December 29, 2022
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family
Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Page
of 20